Medtronic Says Worldwide Voluntary Recall on Guidewires Classified by FDA as Class I Recall

Medtronic (NYSE: MDT ) announced today that the U.S. Food and Drug Administration (FDA) has classified the company's recently initiated voluntary field action related to certain guidewires as a Class I recall. Based on an internal investigation following a limited number of complaints, including one patient injury,